Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail systemic chemotherapy, liver-directed therapies are increasingly being utilized. Yttrium-90 (Y-90) microsphere therapy, also known as selective internal radiation therapy (SIRT) or radioembolization, has proven to be effective in terms of extending time to progression of disease and also providing survival benefit. This review focuses on the use of Y-90 microsphere therapy in the treatment of liver metastases from CRC, including a comprehensive review of published clinical trials and prospective studies conducted thus far. We review the methodology, outcomes, and side effects of Y-90 microsphere therapy for metastatic CRC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110696 | PMC |
http://dx.doi.org/10.3389/fonc.2014.00120 | DOI Listing |
Ann Nucl Med
January 2025
Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Objective: To compare the acute (within 30 days of treatment) laboratory toxicities of Yttrium-90 (Y-90) resin and glass microspheres.
Methods: Selective intra-arterial radionuclide therapies (SIRTs) with Y-90 resin and glass microspheres were retrospectively reviewed. Liver-hematological data were collected at baseline and at 1 week and 1 month follow-up.
Appl Radiat Isot
March 2025
Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, 400085, India; Homi Bhabha National Institute, Mumbai, 400094, India. Electronic address:
The present article describes intricate details involved in the formulation and quality control of 113 ready to use doses of [Y]Y-labeled hydroxyapatite (HA) microparticles for clinical use in radiation synovectomy using Y produced by (n,γ) route. Yttrium-90 was produced with a specific activity of 720 ± 95 MBq/mg of Y and radionuclidic purity of >99.9%.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
December 2024
Ankara University Medical School Department of Nuclear Medicine, Ankara, Turkey.
Purpose: The aim of this study was to investigate the relationship between voxel-based dosimetric variables derived from Y-90 PET/MRI and hypertrophy observed in the left lobe after radioembolization and to investigate if there is any difference in hypertrophy induced by glass versus resin microspheres.
Methods: Voxel-based dosimetry-derived variables and their relationship with the change of the standardized future liver remnant (ΔFLR) was investigated with linear regression models. To compare and evaluate the discriminatory power of the dosimetric variables, ROC analyses were utilized.
Chest
October 2024
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Madinah, Saudi Arabia. Electronic address:
Ann Nucl Med
January 2025
Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey.
Purpose: In this study, we aimed to evaluate the response of the primary and metastatic liver tumors to radioembolization with Y glass microspheres and investigate its correlations with dosimetric variables calculated with Y PET/MRI.
Methods: In this ambispective study, 44 patients treated with Y glass microspheres and imaged with Y PET/MRI were included for analysis. Dosimetric analysis was performed for every perfused lesion using dose-volume histograms.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!